Dr Al-Sayed et al (The Christie NHS Foundation Trust) share their successful QI project to improve patient care in AKI as part of NQICAN Patient First 2016 presentation.
Improving the Effectiveness & Outcomes of Clinical AuditCarl Walker
Dr Venkatesh Kairamkonda talks about how the neonatal unit at UHL have used root cause analysis & PDCA model to make the audits undertaken more effective as part of NQICAN Patient First conference 2016.
Developing an effective local quality improvement programmeCarl Walker
I gave this presentation at Clinical Audit for Improvement conference in October 2016 on behalf of National Quality Improvement & Clinical Audit Network (@nqican)
N-QI-CAN brings together the regional clinical audit / effectiveness networks from across England. There are 14 regional clinical audit/effectiveness networks all of whom have representatives regularly attending NQICAN meetings. Wales and Northern Ireland are also represented on the group to enable sharing of good practice and collaborative working.
NQICAN has several 'stakeholder members' including NHS England, HQIP and NICE. Several of the Royal Colleges and other key stakeholders are represented.
This is the NQICAN annual report for 2016.
Purpose of the Call:
•Speakers from AHS will share:
•AHS’ approach to measurement for improvement (MedRec)
•Lessons learned throughout our measurement journey
•Their approach to using data to drive change at the frontline
Improving the Effectiveness & Outcomes of Clinical AuditCarl Walker
Dr Venkatesh Kairamkonda talks about how the neonatal unit at UHL have used root cause analysis & PDCA model to make the audits undertaken more effective as part of NQICAN Patient First conference 2016.
Developing an effective local quality improvement programmeCarl Walker
I gave this presentation at Clinical Audit for Improvement conference in October 2016 on behalf of National Quality Improvement & Clinical Audit Network (@nqican)
N-QI-CAN brings together the regional clinical audit / effectiveness networks from across England. There are 14 regional clinical audit/effectiveness networks all of whom have representatives regularly attending NQICAN meetings. Wales and Northern Ireland are also represented on the group to enable sharing of good practice and collaborative working.
NQICAN has several 'stakeholder members' including NHS England, HQIP and NICE. Several of the Royal Colleges and other key stakeholders are represented.
This is the NQICAN annual report for 2016.
Purpose of the Call:
•Speakers from AHS will share:
•AHS’ approach to measurement for improvement (MedRec)
•Lessons learned throughout our measurement journey
•Their approach to using data to drive change at the frontline
University of Utah Health Exceptional Value Annual Report 2014University of Utah
Every year the Exceptional Value Annual Report documents the performance of University of Utah Health on all 45 of the key initiatives identified in the organization's Operational Plan. Focused on value-driven outcomes (quality, service and cost), our successes are celebrated and failures are reviewed for learning opportunities.
University of Utah Health Exceptional Value Annual Report 2015University of Utah
Every year the Exceptional Value Annual Report documents the performance of University of Utah Health on all 45 of the key initiatives identified in the organization's Operational Plan. Focused on value-driven outcomes (quality, service and cost), our successes are celebrated and failures are reviewed for learning opportunities.
Discover more about how the West of England AHSN is putting innovation at the heart of healthcare, improving patient outcomes and generating wealth for economic growth.
Purpose of the Call:
•Review the results of the Canadian MedRec Audit Month
•Discuss lessons learned from the audit month – strengths and areas for improvement
•Suggest future value of audits and audit tools for your organization
•Gather ideas about how to improve the quality of MedRec at admission
Watch the recorded webinar: http://bit.ly/19aUYbU
Creating a culture of continuous improvement requires having an AIM or knowing exactly what the organization is striving for.
This means the entire organization should understand the concept of excellence and continually look for ways to do things better and more efficiently, resulting in higher levels of effectiveness.
When everyone understands the aim of excellence, there’s a synergy to achieve that objective. Excellence doesn’t just happen; it’s intentional!
To achieve excellence, you need a systematic approach to improvement initiatives that result in positive change for the organization.
Elective Care Conference: keynote speech from Adam Sewell-JonesNHS Improvement
Outlining NHS Improvement's national priorities and how we'll support providers.The slides accompanied NHS Improvement's Executive Director of Improvement's keynote speech.
This presentation helps to prepare for a quality plan implementation. While working on the elementary steps, studying the internal and external factors, it helps the decision makers to stand by stakeholders boosting the arrival to the designed goals.
Purpose of the Call:
•Recap of aggregated MedRec audit month data that identifies potential opportunities for improvement
•Review quality improvement concepts as it relates to measuring for quality improvement
•Hear how Horizon Health team (NB) is using their data to improve MedRec processes
•Receive a tutorial on how to access your MedRec Quality Score run charts in Patient Safety Metrics.
WATCH: http://bit.ly/1EVcREL
Elective Care Conference: welcome and opening addressNHS Improvement
The aims and agenda of the 4th national Elective Care Conference which took place on 20 April in Leicester. The slides accompanied the opening address given by Nigel Coomber, Director of the Elective Intensive Support Team.
University of Utah Health Exceptional Value Annual Report 2014University of Utah
Every year the Exceptional Value Annual Report documents the performance of University of Utah Health on all 45 of the key initiatives identified in the organization's Operational Plan. Focused on value-driven outcomes (quality, service and cost), our successes are celebrated and failures are reviewed for learning opportunities.
University of Utah Health Exceptional Value Annual Report 2015University of Utah
Every year the Exceptional Value Annual Report documents the performance of University of Utah Health on all 45 of the key initiatives identified in the organization's Operational Plan. Focused on value-driven outcomes (quality, service and cost), our successes are celebrated and failures are reviewed for learning opportunities.
Discover more about how the West of England AHSN is putting innovation at the heart of healthcare, improving patient outcomes and generating wealth for economic growth.
Purpose of the Call:
•Review the results of the Canadian MedRec Audit Month
•Discuss lessons learned from the audit month – strengths and areas for improvement
•Suggest future value of audits and audit tools for your organization
•Gather ideas about how to improve the quality of MedRec at admission
Watch the recorded webinar: http://bit.ly/19aUYbU
Creating a culture of continuous improvement requires having an AIM or knowing exactly what the organization is striving for.
This means the entire organization should understand the concept of excellence and continually look for ways to do things better and more efficiently, resulting in higher levels of effectiveness.
When everyone understands the aim of excellence, there’s a synergy to achieve that objective. Excellence doesn’t just happen; it’s intentional!
To achieve excellence, you need a systematic approach to improvement initiatives that result in positive change for the organization.
Elective Care Conference: keynote speech from Adam Sewell-JonesNHS Improvement
Outlining NHS Improvement's national priorities and how we'll support providers.The slides accompanied NHS Improvement's Executive Director of Improvement's keynote speech.
This presentation helps to prepare for a quality plan implementation. While working on the elementary steps, studying the internal and external factors, it helps the decision makers to stand by stakeholders boosting the arrival to the designed goals.
Purpose of the Call:
•Recap of aggregated MedRec audit month data that identifies potential opportunities for improvement
•Review quality improvement concepts as it relates to measuring for quality improvement
•Hear how Horizon Health team (NB) is using their data to improve MedRec processes
•Receive a tutorial on how to access your MedRec Quality Score run charts in Patient Safety Metrics.
WATCH: http://bit.ly/1EVcREL
Elective Care Conference: welcome and opening addressNHS Improvement
The aims and agenda of the 4th national Elective Care Conference which took place on 20 April in Leicester. The slides accompanied the opening address given by Nigel Coomber, Director of the Elective Intensive Support Team.
Guion de unidades sobre (lo que se manejara como) la asignatura de evaluación docente, describiendo objetivos de cada tema y subtema, su carga horaria. Esto ubicado en quinto semestre de la carrera de pedagogia en la FES Acatlán.
Lista de chequeo polo a tierra gestión de redesJuan Agudelo
esta lista de chequeo fue echa con el fin que que aprendan a como diligenciar la evaluación de un polo a tierra espero buenos comentarios soy torneticor 77 adiós
Julie Henderson (Acting Head of Clinical Services) discusses the Clinical Audit Service:
- Clinical Leadership and Engagement
- Inclusive Approach
- Audit Measurement
This presentation includes two case studies:
1) National Diabetes Audit
2) National Lung Cancer Audit
Measurement for Improvement - Management of Acute Kidney Injury in primary c...Renal Association
Charlie Tomson, Consultant Nephrologist at theFreeman Hospital Newcastle upon Tyne and Chair of the Intervention Workstream, NHS England/UKRR Think Kidneys Programme
presented at a Measurement for Improvement event on 16th March.
North Thames Children's Cancer Network Coordinating GroupUCLPartners
Presentation by Darren Hargrave, Co-Chair of the North Thames Children's Cancer Network Coordinating Group at the London Cancer Children, Teenager and Young Adults Study Day, held on 25 July 2013.
Pathology Optimisation in Chronic Blood Disease MonitoringAndrew O'Hara
Richard Croker shows how an innovative approach to service redesign can improve patient outcomes at pace and scale through the safe and effective use of testing at NHS Northern, Eastern and Western Devon CCG.
Introduction of the NZ Health IT Plan enables better gout management - Reflections of an early adopter. Presented by Peter Gow, Counties Manukau DHB, at HINZ 2014, 12 November 2014, 11.37am, Plenary Room
Presentation made by Celia Ingham Clark National Director for Reducing Premature Mortality, at Improving access to seven day services. Southampton 25 March 2015
Setting up an organisation wide QI programmeAmar Shah
Slides from the session at the International Forum on Quality and Safety in Healthcare (Gothenburg) - Setting up an organisation-wide quality improvement programme
Slides from the Strategic Clinical Network, Cardiovascular Disease Network meeting on 16 January 2015.
The event was run by the Living Longer Lives programme and covers the work we’re doing to implement the Department of Health’s CVD Outcomes strategy, including improving the physical health of people with serious mental illness, supporting the NHS Health Check programme and the GRASP suite of audit tools.
Enhanced Recovery After Surgery (ERAS®) is the Enhanced Recovery After Surgery (ERAS®) is the implementation of patient-focused, standardized, evidencefocused, standardized, evidencefocused, standardized, evidencefocused, standardized, evidencefocused, standardized, evidencefocused, standardized, evidence-based, interdisciplinary perioperative guidelines.
Learn more about Enhanced Recovery Canada:
http://ow.ly/hR3j30jsnjR
Similar to QI initiative: Acute Kidney Injury (AKI) Care in Acute Oncology (20)
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
QI initiative: Acute Kidney Injury (AKI) Care in Acute Oncology
1. The Christie NHS Foundation Trust
Patient First: Preventing Harm Improving care - Quality Improvement Theatre
Clinicians and QI staff -
creating effective partnerships
Quality Improvement Initiative:
Acute Kidney Injury (AKI) Care in Acute Oncology
Dr Tamer Al-Sayed MB ChB FRCP (London) MRCP (Nephrology) SCE (Acute Medicine)
PGCE (PG Medical Education) GC (Medical Physiology & CV/Advanced Renal Specialisation)
Consultant in Acute & Renal Medicine
Acute Kidney Injury Clinical Lead & Sepsis Co-Chair
Honorary Senior Lecturer, Department of Health & Medical Sciences,
The University of Manchester
&
Joanne Woolley, Clinical audit manager
The Christie NHS Foundation Trust
22-23 Nov 2016, London
2. The Christie NHS Foundation Trust
The partnership
• Multiple National drivers: need for compliance with
best practice
• Local clinical concerns: priority for improvement and
innovation
• Clinical audit / QI team support for:
• Development of working group with Executive lead
• Use of AKI alert data collected for national purposes
• Data collection to support patient safety and quality monitoring
• Raising awareness, communicating progress
• Transfer to the electronic patient record and AKI dashboard
• Ongoing review and development
3. The Christie NHS Foundation Trust
Acute Kidney Injury (AKI) at The Christie
• The Christie NHS FT -
comprehensive cancer centre
• largest single site cancer centre in
Europe treating more than 44,000
patients a year
• 18 months ago, new Acute
medicine role appointed
“As a Consultant treating acutely
unwell patients, I have worked
with an expert team to develop
guidelines for staff and patients in
the treatment of acute kidney
injury (AKI)” Dr Al-Sayed
5. The Christie NHS Foundation Trust
The Culture of Audit
• Feeds into clinical effectiveness and research
committee
• Common goal – striving for excellence
• One big team
• Bidirectional interactions
• Strong clinical governance leadership
• Clinical audit a pivotal aspect of quality assurance
• Proactive
• Co-dependent
6. The Christie NHS Foundation Trust
The Christie Experience
• Collaboration with UHSM & AKI working party
• Clinical guidelines developed
• Hotline triage tool
• Audit tool
• New fluid balance forms on OAU
• Patient information leaflet
• NHS Think Kidneys – Showcased work
• Local teaching
• Regional posters and presentations
• NPSA award nomination
• RCP Excellence in patient care submission
• Development of e-learning tool
7. The Christie NHS Foundation Trust
NCEPOD & NICE
• For Better, for worse? – 2008
• Adding insult to injury – AKI 2009
• A time to intervene – 2012
• Just say sepsis – 2015
• NICE AKI guidance 2012
• NICE IV Fluid guidance 2013
• NPSA June 2014 & August 2016
8. The Christie NHS Foundation Trust
Key performance indicators
– facets of a care bundle
• Urine output
• Urinalysis
• Fluid balance
• Critical perfusion pressure
• Oxygenation
• Treatment of sepsis – door to needle times
• Discontinuing toxic medications
• Hand over
• Data recording – audit & governance
9. The Christie NHS Foundation Trust
Telephone triage for patients with suspected AKI
DIARRHOEA
Initial Assessment
Always review last U&E results in patient electronic notes
Questions:
• What chemotherapy is the patient on and when was the last treatment/tablet?
• Are they receiving radiotherapy and when was their last treatment?
• Number of recent episodes?
• How often do the bowels usually move?
• How many stools a day is the patient passing or how much stoma output is there above normal amount?
• Are stools/stoma output formed, loose or watery? Any faecal incontinence or urgency? Nocturnal movements?
• Is there any abdominal pain e.g., cramping pains coming in waves?
• For how many days has the patient had diarrhoea? Is it interfering with activities of daily living?
• Are they able to eat and drink normally? Are they passing plenty of clear urine?
• Do they have any other chemotherapy related toxicities, e.g. mouth ulcers, N/V, red hands/feet, stomatitis, mucositis?
• Any recent antibiotics or recent hospital admissions?
• Have they taken any laxatives or anti-sickness medication or any anti-diarrhoeal medication in the last 24 hours? What?
Advice:
If taking Capecitabine chemotherapy follow the Capecitabine management protocol
DRUGS - NB. Has the patient had a platinum based chemotherapy?
Is the patient taking:
•NSAIDs e.g. Diclofenac, Ibuprofen
•ACE inhibitors e.g. Ramipril, Lisinopril.
NB if patient taking any of the above drugs advise to omit until management plan agreed
10. The Christie NHS Foundation Trust
VOMITING
Initial Assessment
Always review last U&E results in patient electronic notes
Questions:
•Frequency (number of episodes in last 24/48 hours) and nature of nausea with or without vomiting?
•Assess bowel movements; Any symptoms that suggest constipation? Any diarrhoea?
•What food and fluids have you been taking over last few days?
•Any signs of dehydration e.g. decreased urine output, fever, thirst, dry mucous membranes etc.
•What is the underlying cancer diagnosis?
•What is the extent of the disease? – e.g. known metastases to brain, bone, liver etc.
•What medication is the patient taking i.e. antiemetics and has there been any recent changes?
•Increasing abdominal pain?
Advice:
If taking Capecitabine chemotherapy follow the Capecitabine management protocol
DRUGS - NB. Has the patient had a platinum based chemotherapy?
Is the patient taking:
•NSAIDs eg Diclofenac, Ibuprofen
•ACE inhibitors eg Ramipril, Lisinopril.
NB if patient taking any of the above drugs advise to omit until management plan agreed
Review prescribed
antiemetic medication;
Assess patient compliance
Phone / review the patient
in 24 hours
As for grade 1
Advise to get GP review
consider changing antiemetic
including route of admin.
Phone / review the patient in
24 hours
If symptoms worsen or are
associated with other toxicities
consider admission.
Urgent review required or discuss with Acute
Physician on MAU.
11. The Christie NHS Foundation Trust
Time Oral Intake Running
Total
IV 1 IV 2/ Other Running
Total
Total
Intake
07: 00
08: 00
09: 00
10: 00
11: 00
12: 00
13: 00
14: 00
15: 00
16: 00
17: 00
18: 00
19: 00
20: 00
21: 00
22: 00
23: 00
24: 00
01: 00
02: 00
03: 00
04: 00
05: 00
06: 00
TOTAL
INTAKE
Urine Running
Total
Other Other Running
Total
Total
Output
TOTAL
OUTPUT
Balance from
previous day:
Cumulative
balance:
Weight:
Balance from
previous day:
Cumulative
balance:
Weight:
BALANCE
Developed by Katerina Pearson, OAU Sister
12. The Christie NHS Foundation Trust
AKI alert and guidance on blood result
14. The Christie NHS Foundation Trust
AKI alerts post change in algorithm
• Initial audit identified need for change in algorithm to
improve accurate classification of AKI stage
• Increased numbers identified; level 3 maintained
15. The Christie NHS Foundation Trust
AKI alerts: quality monitoring
and improvement
• Adherence to care bundle and root cause analysis
• Policy, guidance, education, awareness raising
16. The Christie NHS Foundation Trust
Assessing risk factors on admission
17. The Christie NHS Foundation Trust
Monitoring compliance with care bundle
• Early increased compliance since pilot, eg.:
• Ultrasound KUB <24hours: up from 51% to 60%
• Stop nephrotoxic medications: up from 54% to 63%
• Urine dipstick and analysis: up from 54% to 67%
18. The Christie NHS Foundation Trust
Strong Leadership
Focus within The Christie:
• Governance – clinical audit leadership and
steering
• Clinical specialist leadership
• Executive board membership
• Embedding data collection into clinical
systems
• Empowering staff to collect data
• Assigning trainees with current projects
19. The Christie NHS Foundation Trust
Sharing & Promoting Best Practice
• Executive dissemination
• Education – Presentations
• Non-medical prescribers
• Acute Oncology Masterclass for NW AON
• Morbidity & Mortality Grand Round
• Representation at the GM, Lancashire & South
Cumbria Strategic Clinical Network
• National patient safety presentations
• GP correspondence
• Link with sepsis and IV fluid groups
20. The Christie NHS Foundation Trust
Practical Solutions – Real Problems
• Clinical audit will assure delivery and
quality of this entire project through
robust long term data collection &
analysis
• AKI Dashboards – safety thermometer
• EPR – AKI documentation
• e-prescribing – medicines optimization
• e-learning tools
• AKI discharge summaries for GP & patients
21. The Christie NHS Foundation Trust
Simple is Effective
Maximising the utility of clinical audit
A fully integrated team
Pioneering in Cancer Care in the UK
Innovative & Expert real time cross disciplinary team
working beyond historical barriers
The power of a culture shift
A new tradition
Medicines optimization
Proactivity at the front door
Maximising patient outcomes
22. The Christie NHS Foundation Trust
References & Resources
• AKI toolkit 12 – RCP Oct 2015
• AKI APP – RCPE
• NICE AKI Guidance 2012
• NCEPOD – Adding Insult to Injury 2009
• NHS ‘Think Kidneys’ programme
• Academy of Medical Royal Colleges
• Royal College of Radiology – Contrast Nephropathy
• Society of Intensive Care Medicine
• Society for Acute Medicine
• Royal College of Nursing
• Royal Society of Medicine – Nephrology section
• Renal Association/British Renal Society website